NPC Heads to AMCP 2026

Look for the NPC team at this year's AMCP Annual meeting in Nashville, TN. 

Tuesday | 1:30 PM - 2:45 PM CT

Education Session: The Accelerated Approval Program: Balancing Crucial Patient Access with Timely Evidentiary Needs

Faculty:

• Bridget M. Doherty, MPH, MS, Director, Access and Policy Research, Johnson & Johnson Innovative Medicine
• Timothy O'Shea, MS, PharmD, Director, Specialty Pharmacy, Horizon Blue Cross Blue Shield of New Jersey
• Tyler D. Wagner, PharmD, PhD, Director of Research, National Pharmaceutical Council

Session Details:

The FDA’s Accelerated Approval Program (AAP) has long served as a critical mechanism to expedite patient access to promising therapies for serious or life-threatening conditions. Now, its balance between timely access and evidentiary rigor is under renewed attention. In recent years, payers have increasingly adopted a more cautious stance toward therapies approved under the AA program, particularly in non-oncology medicines, reflecting payers’ concerns around the uncertainty of clinical benefits.

This session will investigate trends in the AA program over time, including an examination of the current landscape, expected future volume of therapies applying for and being approved under the AA program, and trends related to oncology and non-oncology therapeutic areas. The session will also discuss policy updates aimed at reforming the AAP and highlight the perspectives of manufacturers, payers, and patients, both where there is consensus and where there is disagreement about the future of the program.

Tuesday | 6:00 – 7:00 PM CT

Student and New Practitioner Networking Event 

NPC is once again sponsoring the AMCP Annual Student and New Practitioner Networking Event! Come mingle with our team during a lively reception focused on sharing advice, career opportunities, and industry insights.

Wednesday | 12:00 – 1:00 PM CT

Research Poster: Characterizing Subsequent Indications Following Accelerated Approval of Non-oncology Medicines in the U.S.

NPC Associate Director of Research Hanke Zheng will present findings from her research on "Characterizing Subsequent Indications Following Accelerated Approval of Non-oncology Medicines in the U.S."

Research Poster: Breadth of Medicare Part D Preferred Pharmacy Networks, 2019-2025.

NPC Director of Research Tyler Wagner will present his team’s research on the “Breadth of Medicare Part D Preferred Pharmacy Networks, 2019-2025.”